| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-17 14:22 Tx date 2025-10-17 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,322.16
-3,132 vol $1.38 each |
324 | |
| Filed 2025-10-17 14:21 Tx date 2025-10-17 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,115.60
-3,654 vol $1.40 each |
3,456 | |
| Filed 2024-03-10 23:15 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,222 vol |
10,801 | |
| Filed 2023-12-14 21:24 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,883 vol |
7,110 | |
| Filed 2023-12-14 21:23 Tx date 2023-03-19 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-12,776 vol |
77,224 | |
| Filed 2023-12-14 21:20 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-26,667 vol |
8,579 | |
| Filed 2023-12-14 21:19 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-19,264 vol |
35,246 | |
| Filed 2023-12-14 21:18 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-22,714 vol |
54,510 | |
| Filed 2022-06-23 13:00 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
||
| Filed 2022-06-09 22:42 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
||
| Filed 2022-06-09 22:42 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
120,000 | |
| Filed 2022-06-08 18:24 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+30,000 vol $1.60 each |
90,000 | |
| Filed 2022-06-08 17:57 Tx date 2021-09-24 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-686,291 vol |
63,993 | |
| Filed 2021-10-06 10:52 Tx date 2021-09-24 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-686,376 vol |
||
| Filed 2021-12-21 21:46 Tx date 2021-12-21 |
$XRX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$55,044
+21,671 vol $2.54 each |
60,000 | |
| Filed 2021-10-06 10:55 Tx date 2021-09-24 |
$XRX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-274,447 vol |
38,329 | |
| Filed 2021-10-06 10:53 Tx date 2021-09-24 |
$XRX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-137,224 vol |
312,776 | |
| Filed 2021-10-06 10:52 Tx date 2021-09-24 |
$XRX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-686,376 vol |
63,908 | |
| Filed 2021-03-01 10:04 Tx date 2021-02-26 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$89,285
+357,142 vol $0.25 each |
750,284 | |
| Filed 2021-03-01 10:03 Tx date 2021-02-26 |
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.) |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-357,142 vol |
0 |